Treatments Archives - Clinical Advisor

Small Intestinal Bacterial Overgrowth Linked to Poor Outcomes in Patients With Heart Failure

By

Colby Stong

May 6, 2021

Investigators sought to determine the prevalence of small intestinal bacterial overgrowth and establish its prognostic value in patients with heart failure.

Psychiatry Information Center

Medication-Assisted Treatment is Cost-Effective for Opioid Use Disorder

By

Jessica Nye, PhD

April 14, 2021

The researchers sought to assess the cost-effectiveness of OUD treatments and association of treatments with outcomes in the United States.

Oncology Information Center

The Role of Nurse Practitioners as Prescribers in Cancer Treatment

By

Vicki Moore, PhD

May 5, 2021

Nurse practitioners play an essential role in the chemotherapy plan for patients with cancer.

Diabetes Information Center

Spinal Cord Stimulation May Provide Relief in Painful Diabetic Neuropathy

By

Jessica Nye, PhD

April 29, 2021

At follow-up, 65.9% of the treatment group and 8.5% of the control cohort exhibited improvements in painful diabetic neuropathy.

News

Intranasal Ketamine Reduces Pain and Concomitant Drug Use for Refractory Headache

By

Jessica Nye, PhD

April 29, 2021

This study assessed the efficacy and safety of intranasal ketamine as an outpatient treatment for refractory headache.

Type 2 Diabetes Information Center

Gender, Race Affects Access to SGLT2-Inhibitor Therapy for Type 2 Diabetes

April 26, 2021

Black race, Asian race, and female gender were associated with lower rates of SGLT2 inhibitor use in patients with type 2 diabetes.

Infectious Diseases Information Center

Artesunate for Injection Now Available for Severe Malaria

By

Diana Ernst, RPh

April 12, 2021

Artesunate and its metabolite DHA are both active against the blood-stage asexual parasites and gametocytes of Plasmodium species including the chloroquine resistant strains.

Pain Information Center

Research Highlights Emerging Novel Interventions for Neuropathic Pain

By

Brandon May

April 7, 2021

Study authors discuss recent advances in the interventional management of neuropathic pain; new therapies are needed to offer longitudinal and sustained management.

Chronic plaque psoriasis is a condition in which epithelial cells are over produced and form a well-defined site. The redness is often covered with silvery scales of skin. The cause of this type of psoriasis is unknown, but some inheritance factor has been reported, as has a connection with stress disorders. Treatment is normally by palliative creams based on coal tar, although some acute cases are treated with drugs.

Psoriasis Information Center

Real-World Study: Guselkumab May Be Effective for Moderate to Severe Plaque Psoriasis

By

Brandon May

March 10, 2021

Real-world data from patients with plaque psoriasis treated with guselkumab, who had previously been administered biologic agents is presented.

Dermatology Information Center

Emerging Therapies Show Promise for Atopic Dermatitis

By

Colby Stong

March 8, 2021

The effectiveness and safety of systemic immunomodulatory treatments for patients with atopic dermatitis are compared in a systematic review and network meta-analysis.